Comparability of antimüllerian hormone levels among commercially available immunoassays H. Irene Su, M.D., M.S.C.E., Mary D. Sammel, Sc.D., Michael V. Homer, M.D., Kim Bui, M.S., Carolyn Haunschild, M.S., Frank Z. Stanczyk, Ph.D. Fertility and Sterility Volume 101, Issue 6, Pages 1766-1772.e1 (June 2014) DOI: 10.1016/j.fertnstert.2014.02.046 Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions
Figure 1 (A) Passing and Bablok plots and fit analysis, which depict the linear regression line and 95% CI relative to a slope of 1, compare untransformed Gen II and Ultrasensitive AMH assay results. (B) Gen II AMH and picoAMH assay results. (C) Ultrasensitive AMH and picoAMH assay results. Spearman correlation coefficients (r) are shown for comparisons. (D) Bland-Altman plots, which depict the difference in AMH values relative to the mean of the two assays, compare Gen II and Ultrasensitive AMH assay results. (E) Gen II AMH and picoAMH assay results. (F) Ultrasensitive AMH and picoAMH assay results. Fertility and Sterility 2014 101, 1766-1772.e1DOI: (10.1016/j.fertnstert.2014.02.046) Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions
Supplemental Figure 1 Passing and Bablok plot and fit analysis, which depict the linear regression line and 95% CI relative to a slope of 1, compare log-transformed Gen II and Ultrasensitive AMH assay results (A). Spearman correlation coefficient (r) is shown in the comparison. Bland-Altman plot, which depicts the difference in AMH values relative to the mean of the two assays, compares Gen II and Ultrasensitive AMH assay results (B). Fertility and Sterility 2014 101, 1766-1772.e1DOI: (10.1016/j.fertnstert.2014.02.046) Copyright © 2014 American Society for Reproductive Medicine Terms and Conditions